Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Gains from Investment Securities (2014 - 2015)

Exelixis (EXEL) posted quarterly Gains from Investment Securities of $730000.0 for Q2 2019, up 249.28% quarter-over-quarter from $209000.0 in Q1 2018.

Analysis

Exelixis (EXEL) Gains from Investment Securities (2014 - 2015) Analysis & Trends

Exelixis' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $730000.0 for Q2 2019.

  • In Q2 2019, Gains from Investment Securities changed N/A year-over-year to $730000.0; the TTM figure through Sep 2019 stood at $730000.0 (up 249.28% YoY), while the FY2018 annual figure was $209000.0, down 92.99% from the prior year.
  • Gains from Investment Securities for Q2 2019 stood at $730000.0, up from $209000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $2.5 million in Q3 2016, with the low at $209000.0 in Q1 2018.
  • The 5-year median for Gains from Investment Securities is $730000.0 (2019), against an average of $1.3 million.
  • The sharpest annual moves came in 2015 and 2017: Gains from Investment Securities jumped 131.57% in 2015, then dropped 6.13% in 2017.
  • Exelixis' Gains from Investment Securities stood at $549000.0 in 2015, then jumped by 254.28% to $1.9 million in 2016, then advanced by 20.36% to $2.3 million in 2017, then plunged by 91.07% to $209000.0 in 2018, then soared by 249.28% to $730000.0 in 2019.
  • Business Quant data shows EXEL's Gains from Investment Securities at $730000.0 in Q2 2019, $209000.0 in Q1 2018, and $2.3 million in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 549,000.00
Dec 31, 2014 76,000.00
Sep 30, 2014 -62,000.00
Jun 30, 2014 -115,000.00
Mar 31, 2014 -1.74 Mn